Furthermore, ALT and gamma‐glutamyl transferase levels were shown to decrease in patients with NAFLD treated with a combination of nicotinamide riboside and pterostilbene (NRPT) (Dellinger et al. 2023). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.